论文部分内容阅读
目的观察七味胃痛胶囊联合三联用药治疗胃黏膜病变的临床疗效。方法选取胃黏膜病变患者100例,随机分为试验组和对照组各50例,对照组采用三联疗法,试验组在对照组的治疗基础上给予七味胃痛胶囊口服,比较2组疗效。结果试验组总有效率为92.0%明显高于对照组的78.0%,差异有统计学意义(P<0.05)。结论七味胃痛胶囊联合三联用药治疗胃黏膜病变的疗效优于三联用药,值得临床推广。
Objective To observe the clinical effect of Qiwei Weitong capsule combined with triple therapy on gastric mucosal lesions. Methods 100 cases of gastric mucosal lesions were selected and randomly divided into experimental group and control group, 50 cases in each group. The control group was treated with triple therapy. The experimental group was given Qiweitongtong capsule orally on the basis of the control group. The curative effect was compared between the two groups. Results The total effective rate was 92.0% in the experimental group was significantly higher than 78.0% in the control group, the difference was statistically significant (P <0.05). Conclusion The therapeutic effect of Qiwei Weitong capsule combined with triple therapy on gastric mucosal lesions is superior to triple therapy, which is worthy of clinical promotion.